MedTrace Logo

Adaptive Physical Activity for Chronic Stroke

NCT00773370 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2016-08-15

Study results available
· View outcomes & findings →

Summary

This study will compare the Adaptive Physical Activity program (APA) to a less vigorous group exercise program, (Sittercise) to see if APA leads to greater improvements in walking endurance, quality of life, and participation in social activities.

Conditions

Interventions

BEHAVIORAL

APA-Stroke

Exercise program design specifically for individuals with residual hemiparetic gait deficits due to stroke. Exercises are progressive, beginning with a 5 minute walk at the beginning and end of each class and gradually progressing to a 15 minute walk at the beginning and end of each class. Exercises focus on walking and are designed to improve walking ability and balance. Program includes a homework component.

BEHAVIORAL

Sittercise

Not stroke specific. This less vigorous exercise program consists of seated exercise focusing on stretching to improve general range of movement and weight exercises to strengthen the trunk, arms, and legs. There is no assigned exercise homework.

Sponsors & Collaborators

  • University of Maryland, Baltimore County

    collaborator OTHER

  • Howard County Office on Aging

    collaborator UNKNOWN

  • MedStar National Rehabilitation Network

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Mary Stuart, ScD · VA Maryland Health Care System, Baltimore

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2014-02-28
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00773370 on ClinicalTrials.gov